Showing results (61-70 of 81) with videos related to
Sort By:
Pageof 9
Journal of Medicinal Chemistry|November 11, 2022
Site-Specific Radiohalogenation of a HER2-Targeted Single-Domain Antibody Fragment Using a Novel Residualizing Prosthetic AgentYutian Feng, Samantha M Sarrett, Rebecca L Meshaw, et al.Nuclear Medicine and Biology|May 4, 2024
PSMA-reactive NB7 single domain antibody fragment: A potential scaffold for developing prostate cancer theranosticsTruc T Huynh, Yutian Feng, Rebecca Meshaw, et al.Bioconjugate Chemistry|March 18, 2004
O6-3-[131I]iodobenzylguanine: improved synthesis and further evaluation of a potential agent for imaging of alkylguanine-DNA alkyltransferaseGanesan Vaidyanathan, Donna J Affleck, Joseph Norman, et al.European Journal of Nuclear Medicine and Molecular Imaging|November 1, 2013
Synthesis and evaluation of 18F-labeled benzylguanidine analogs for targeting the human norepinephrine transporterHanwen Zhang, Ruimin Huang, NagaVaraKishore Pillarsetty, et al.Nuclear Medicine and Biology|August 27, 2014
N-Succinimidyl guanidinomethyl iodobenzoate protein radiohalogenation agents: influence of isomeric substitution on radiolabeling and target cell residualizationJaeyeon Choi, Ganesan Vaidyanathan, Eftychia Koumarianou, et al.Nuclear Medicine and Biology|May 4, 2024
A third generation PSMA-targeted agent [<sup>211</sup>At]YF2: Synthesis and in vivo evaluationYutian Feng, Rebecca L Meshaw, Sean W Finch, et al.Molecular Pharmaceutics|June 8, 2026
Synthesis and Preliminary Evaluation of the <sup>211</sup>At-Labeled PARP Inhibitor [<sup>211</sup>At]Talazoparib as a Targeted Alpha-Particle Emitting TherapeuticYongxiang Zheng, Deyu Kong, Truc T Huynh, et al.Bioorganic & Medicinal Chemistry|March 28, 2007
A kit method for the high level synthesis of [211At]MABGGanesan Vaidyanathan, Donna J Affleck, Kevin L Alston, et al.Molecular Imaging and Biology|April 15, 2017
Fluorine-18 Labeling of the HER2-Targeting Single-Domain Antibody 2Rs15d Using a Residualizing Label and Preclinical EvaluationZhengyuan Zhou, Ganesan Vaidyanathan, Darryl McDougald, et al.Neuro-Oncology Advances|September 21, 2022
Low-level whole-brain radiation enhances theranostic potential of single-domain antibody fragments for human epidermal growth factor receptor type 2 (HER2)-positive brain metastasesDaniele Procissi, Stephen A Jannetti, Markella Zannikou, et al.Pageof 9